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The L protein of Bunyamwera virus (BUNV; family Bunyaviridae) is an RNA-dependent RNA
polymerase, 2238 aa in length, that catalyses transcription and replication of the negative-sense,
tripartite RNA genome. To learn more about the molecular interactions of the L protein and to
monitor its intracellular distribution we inserted a 14 aa V5 epitope derived from parainfluenza
virus type 5, against which high-affinity antibodies are available, into different regions of the
protein. Insertion of the epitope at positions 1935 or 2046 resulted in recombinant L proteins that
retained functionality in a minireplicon assay. Two viable recombinant viruses, rBUNL4V5 and
rBUNL5V5, expressing the tagged L protein were rescued by reverse genetics, and characterized
with respect to their plaque size, growth kinetics and protein synthesis profile. The recombinant
viruses behaved similarly to wild-type (wt) BUNV in BHK-21 cells, but formed smaller plaques and
grew to lower titres in Vero E6 cells compared with wt BUNV. Immunofluorescent staining of
infected cells showed the L protein to have a punctate to reticular distribution in the cytoplasm,
and cell fractionation studies indicated that the L protein was present in both soluble and
microsomal fractions. Co-immunoprecipitation and confocal microscopic assays confirmed an
interaction between BUNV L and N proteins. The recombinant viruses expressing tagged L
protein will be highly valuable reagents for the detailed dissection of the role of the BUNV L
protein in virus replication.
INTRODUCTION
The family Bunyaviridae contains more than 300 members
and is divided into five genera, Orthobunyavirus,
Hantavirus, Nairovirus, Phlebovirus and Tospovirus.
Several members are important human pathogens, such
as La Crosse orthobunyavirus (LACV), Hantaan hanta-
virus, Rift Valley fever phlebovirus and Crimean-Congo
hemorrhagic fever nairovirus. Bunyamwera virus (BUNV)
is the prototype of both the genus Orthobunyavirus and the
family. Like other members of the family Bunyaviridae,
BUNV possesses a tripartite, negative-sense RNA genome
that encodes four structural proteins. The largest segment
(L) codes for the L protein, an RNA-dependent RNA
polymerase (RdRp); the medium segment (M) codes for a
precursor that is co-translationally cleaved into the two
glycoproteins (Gn and Gc) and a non-structural protein
(NSm); and the small segment (S) codes for the
nucleoprotein (N) and a second non-structural protein
(NSs) in overlapping reading frames (Elliott, 1996; Nichol
et al., 2005; Schmaljohn & Hooper, 2001). Bunyaviruses
replicate in the cytoplasm of infected cells, and assemble
and bud in the Golgi complex (Kuismanen et al., 1982;
Murphy et al., 1973; Schmaljohn & Hooper, 2001).
The bunyavirus L protein is the catalytic enzyme for
replication of the RNA genome and transcription of viral
mRNAs; only the L and N proteins are required for these
processes (Dunn et al., 1995; Lopez et al., 1995). In
common with all negative-strand RNA viruses, the viral
genomic (2) and antigenomic (+) RNAs are complexed
with the N protein to form ribonucleoproteins (RNP) that
serve as templates for viral transcription and replication
(Ortin & Parra, 2006). The BUNV L protein is 259 kDa
and contains 2238 aa (Elliott, 1989). Although no extended
homology is found with other negative-stranded virus
polymerases or even with the polymerases of viruses in
other genera in the family Bunyaviridae, the motifs
conserved in other RdRps that comprise the ‘polymerase
module’ have been identified (Aquino et al., 2003; Elliott,
1989; Gowda et al., 1998; Muller et al., 1994; Poch et al.,
1989; Quinan et al., 2008; Roberts et al., 1995; van Poelwijk
et al., 1997). Its role as the viral polymerase was confirmed
by the ability of the L protein to transcribe authentic
BUNV RNP templates (Jin & Elliott, 1991).
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Few studies have reported the intracellular location of
bunyavirus polymerase proteins. LACV RNA synthesis was
demonstrated to occur in the cytoplasm by RNA pulse-
labelling and cell fractionation (Rossier et al., 1986),
implying the presence of the L protein. The L protein of
Toscana phlebovirus (TOSV) was observed to have a
punctate staining pattern in the cytoplasm of infected cells
as detected with a monospecific antibody raised against a
bacterially expressed fragment of the L protein (Di Bonito et
al., 1999; Kukkonen et al., 2004), while transient expression
of the Tula hantavirus (TULV) L protein fused to green
fluorescent protein (GFP) also showed a cytoplasmic
perinuclear distribution (Di Bonito et al., 1999; Kukkonen
et al., 2004). The ‘viral factory’ assembled by BUNV was
described and characterized (Novoa et al., 2005; Salanueva et
al., 2003); the factory contains novel tubular structures with
a globular head, and electron microscopical studies showed
the presence of the BUNV L protein and dsRNA in the
globular head (Fontana et al., 2008).
To elucidate further the biological function of the
bunyavirus RNA polymerase, the BUNV L protein was
tagged with a 14 aa V5 epitope derived from the
parainfluenza virus type 5 protein (Southern et al., 1991)
and two recombinant viruses (rBUNV-L4V5 and rBUNV-
L5V5) expressing tagged L protein were rescued by reverse
genetics. We demonstrated that the tagged L protein
interacted with the viral N protein and formed punctate to
reticular membranous structures in the cytoplasm of virus-
infected cells. The effect of the V5 insertion on replication
was also assessed with the two recombinant viruses.
METHODS
Cells and viruses. Vero E6 (ATCC C1008), BHK-21 and BSR-T7/5
(Buchholz et al., 1999) cells were maintained as described previously
(Shi et al., 2005). Working stocks of wild-type (wt) and recombinant
BUNV were grown in BHK-21 cells and titres were determined by
plaque assay as detailed previously (Watret et al., 1985).
Antibodies. Anti-N, a rabbit antiserum against BUNV nucleocapsid
protein, was described previously (Lappin et al., 1994; Weber et al.,
2001). An anti-V5 mAb was purchased from Serotec. A rabbit
polyclonal antibody against GM130, a cis-Golgi matrix protein
(Nakamura et al., 1995), was provided by Dr M. Lowe (School of
Biological Sciences, University of Manchester, UK). Goat anti-rabbit
antibody conjugated to fluorescein isothiocyanate was purchased
from Sigma, and goat anti-mouse antibody conjugated to Cy5 was
purchased from Amersham Phamacia Biotech.
Plasmids. Plasmids that either express BUNV proteins (pTM1-
BUNL for expressing L protein, and pTM1-BUNS for expressing N
and NSs), or generate full-length antigenomic RNA transcripts
[pT7riboBUNL(+), pT7riboBUNM(+), pT7riboBUNS(+)] have
been described previously (Bridgen & Elliott, 1996; Lowen et al.,
2004), as have the BUNV-derived minigenome expressing construct,
pT7riboBUNMREN(2), that contains the Renilla luciferase gene in
the negative-sense (Weber et al., 2001), and the control plasmid
pTM1-FF-Luc that expresses firefly luciferase (Weber et al., 2002).
The V5 epitope (GKPIPNPLLGLDST) (Southern et al., 1991) was
inserted into the BUNV L protein coding region in both pTM1-
BUNL and pT7riboBUNL(+) as shown in Fig. 1 by using a PCR
mutagenesis approach (Shi & Elliott, 2002). Ten V5-tagged BUNV L
mutants were constructed, five derived from pTM1-BUNL (desig-
nated pTM1-BUNL1V5–pTM1-BUNL5V5) and five based on
pT7riboBUNL(+) (pT7riboBUNL1V5–pT7riboBUNL5V5). All con-
structs were confirmed by DNA sequence analysis. The primers used
and details of PCR amplification are available upon request.
Indirect immunofluorescence staining. Immunofluorescence
assays were performed as described previously (Shi & Elliott, 2002).
Briefly, transfected or infected BSR-T7/5 cells grown on glass
coverslips of 13 mm diameter were fixed with 4% paraformaldehyde
in PBS and permeabilized with 0.1% Triton X-100 in PBS before
staining with the specific primary antibodies and secondary antibody
conjugates. Localization of fluorescently labelled proteins was
examined using either a Zeiss LSM confocal microscope or
DeltaVision 3.5 Restoration Microscope (Applied Precision) as
indicated in the Figure legends. The DeltaVision images were
processed with deconvolution software (softWoRx; Applied
Precision) to remove the non-specific noise in the images.
BUNV minireplicon assay. The BUNV minireplicon assay was
performed as described previously (Kohl et al., 2004) with minor
modifications. Briefly, BSR-T7/5 cells were transfected with pTM1-
BUNS (0.1 mg) and pTM1-BUNL (0.3 mg), or one of the mutated L
segment cDNAs cloned into pTM1 (also 0.3 mg), together with the
minigenome plasmid, pT7riboBUNMREN(2) (0.3 mg), and pTM1-
FF-Luc (0.1 mg) (internal transfection control). At 24 h post-
transfection, Renilla and firefly luciferase activities were measured
using the Dual-Luciferase Assay kit (Promega) according to the
manufacturer’s instruction.
Subcellular fractionation by ultracentrifugation. Preparation of
total microsomal fractions of rBUNL4V5-infected BHK-21 cells was
performed as described previously (Ehrenreich et al., 1973) with
modifications. Briefly, BHK-21 cells grown in a 175 cm2 flask were
infected at an m.o.i. of 1.0 p.f.u. per cell and incubated for 36 h. Cells
were washed twice with cold PBS and once with 0.25 mM sucrose/
10 mM HEPES buffer (pH 7.2) by centrifugation at 700 g for 3 min
at 4 uC. The cell pellet was resuspended in 1.0 ml 0.25 mM sucrose/
10 mM HEPES buffer and disrupted by three freeze–thaw cycles on
dry ice–37 uC, followed by three 10 s pulses of sonication in a water
bath at 4 uC, and then 10 strokes in a glass homogenizer. After
clarification at 1000 g for 10 min at 4 uC, the supernatant (total
fraction, T) was further centrifuged at 65 000 r.p.m. for 15 min
(Beckman TL-100 rotor) to produce a soluble fraction (S) and pellet
Fig. 1. Construction of the V5 epitope-tagged BUNV L protein.
The 14 aa V5 epitope was inserted into the coding region of the L
proteins by using PCR mutagenesis with both pTM1-BUNL and
pT7riboBUNL DNA as template. The insertion sites are indicated
by triangles with the residue number shown below and were
designated L1V5–L5V5. The dotted area represents the pre-
dicated catalytic RdRp domains of the BUNV L protein.
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(microsomal fraction, Mi). Samples from all fractions were analysed
by SDS-PAGE and Western blotting.
Metabolic radiolabelling and immunoprecipitation. Metabolic
radiolabelling and immunoprecipitation of BUNV proteins were
performed as described previously (Shi et al., 2005). Briefly, cells were
labelled with [35S]methionine (Amersham Pharmacia Biotech) at
various time points post-infection or at 16 h post-transfection as
indicated in the Figure legends. The labelled cells were either analysed
directly by SDS-PAGE or lysed for immunoprecipition on ice with
300 ml non-denaturing RIPA buffer (50 mM Tris/HCl, pH 7.4, 1%
Triton X-100, 300 mM NaCl, 5 mM EDTA) containing a cocktail of
protease inhibitors (Roche). BUNV proteins were immunoprecipitated
with anti-N or anti-V5 antibodies that had been conjugated to Protein
A–agarose (Sigma). The beads were washed with RIPA buffer contain-
ing 0.1% Triton X-100 and once with ice-cold PBS, and the bound
proteins were analysed by SDS-PAGE under reducing conditions.
Virus rescue by reverse genetics. Rescue experiments were
performed as described previously (Lowen et al., 2004). Briefly,
BSR-T7/5 cells were transfected with a mixture of three plasmids:
1.0 mg each pT7riboBUNM(+), pT7riboBUNS(+) and either
pT7riboBUNL(+) or one of the pT7riboBUNL(+)-derived V5-
tagged L cDNA mutants. At 6 h post-transfection, 4 ml growth
medium was added and incubation continued. Rescues were
attempted at least twice for each construct, and transfected cells were
maintained for up to 14 days or until cytopathic effects (CPE) were
evident. The transfectant viruses were isolated by plaque formation on
Vero E6 cells.
RESULTS
Generation of V5-tagged BUNV L protein
Although the BUNV L protein plays a key role in viral
replication and transcription, it is the least characterized of
all the structural proteins. Previously, we described the
effects of some specific mutations on the activity of the
BUNV L protein (Dunn et al., 1995; Jin & Elliott, 1992),
and produced monospecific antibodies that recognized the
L protein in immunoprecipitation and Western blotting
procedures (Jin & Elliott, 1992). Unfortunately, although
these antibodies recognize the L protein by immunogold
labelling of thin sections of glutaraldehyde-fixed infected
cells and electron microscopy (Fontana et al., 2008), they
do not detect the L protein when used for immunofluor-
escent staining of infected cells (unpublished observations),
thus limiting investigations on the intracellular distribution
of the L protein. Therefore, we attempted to modify the L
protein by the addition of specific epitopes; however,
fusing the Flag-tag to either the N or C terminus of the L
protein resulted in severe loss of activity in our mini-
replicon assay (F. Weber & R. M. Elliott, unpublished
data). Prompted by the report of Duprex et al. (2002) that
the measles virus L protein could tolerate insertion of GFP
and retain function, we targeted internal regions of BUNV
L for the insertion of the V5 epitope from parainfluenza
virus type 5 (Southern et al., 1991). Based on alignment of
the L protein amino acid sequences from three orthobu-
nyaviruses (BUNV, LACV and oropouche virus) and
bioinformatic predictions of the BUNV L protein using
programs in the protein structure server SCRATCH (http://
www.ics.uci.edu/~baldig/scratch/) (Cheng et al., 2005), the
following criteria were considered to determine sites for
possible insertion: regions of higher variability, regions
predicted to have fewer residue contacts and relative higher
solvent accessibility, and regions that avoided predicted a-
helix and b-strand structures (see Supplementary Fig. S1
available in JGV Online). Five sites were identified that
fulfilled these criteria and plasmids expressing the V5-
tagged BUNV L proteins were constructed (Fig. 1).
Intracellular localization and polymerase activity
of V5-tagged L proteins
The accessibility of the V5 epitope in the recombinant L
proteins was assessed by immunofluorescent staining of
plasmid-transfected cells (Fig. 2a). Except for L2V5, all V5-
tagged L proteins displayed a cytoplasmic, punctate to
reticular staining pattern [Fig. 2a, panels (i), (iii)–(v)]
[clearly shown in the magnified insets in panels (i) and
(iv)], suggesting that the L protein may be associated with
intracellular membrane compartments. When the V5
epitope was inserted at position 428 (construct L2V5), a
different staining pattern was observed that was suggestive
of the aggregation of misfolded protein.
The effect of these insertions on the functionality of L
protein was assessed using the minireplicon reporter assay
on BSR-T7/5 cells. As shown in Fig. 2(b), insertions of the
V5 tag at positions 148 (L1V5), 428 (L2V5) and 863 (L3V5)
abolished polymerase activity in the minireplicon assay.
Polymerases with insertions towards the C terminus at
positions 1935 (L4V5) and 2046 (L5V5) were still functional,
though with reduced activity compared with that of wt
BUNV L of 18 (L4V5) and 4% (L5V5), respectively.
Rescue of recombinant viruses expressing V5-
tagged L protein
The five recombinant L cDNAs were next used for virus
rescue to assess the effect of the V5 insertion on virus
viability (Lowen et al., 2004). Consistent with the results
from the minireplicon assay, recombinant viruses were
recovered from the two functional V5-tagged L constructs,
pT7riboBUNL(+)-L4V5 and -L5V5 (the rescued viruses
were designated rBUNL4V5 and rBUNL5V5, or rL4V5 and
rL5V5 for short), whereas no virus was rescued from the
non-functional constructs pT7riboBUNL(+)-L1V5, -L2V5
and -L3V5.
The presence of V5 tag in the L protein of the recombinant
viruses was confirmed by Western blotting analysis of
infected BHK-21 and Vero E6 cells (Fig. 3). The L proteins
of rBUNL4V5 and rBUNL5V5 were detected by anti-V5
mAb, whereas no signal was seen in lysates of cells infected
with wt BUNV control. The N protein was also clearly
detected in cells infected by both wt BUNV and the V5-
tagged mutant viruses (Fig. 3).
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Effect of V5 insertions of the L protein on rBUNV
growth and protein synthesis in cell culture
The effects of the V5 insertion in the viral polymerase on
virus viability, plaque size, growth kinetics and the ability
to shut-off host protein synthesis were compared with
those of wt BUNV. As shown in Fig. 4, insertion of the V5
epitope had differential impacts on virus growth in BHK-
21 and Vero E6 cells. In BHK-21 cells, the plaques formed
by rL4V5, rL5V5 and wt BUNV were similar in size
(Fig. 4a). This was consistent with the virus growth kinetics
on BHK-21 cells, in which the titre of two recombinant
Fig. 2. Characterization of the V5-tagged BUNV L protein. (a) Intracellular localization of the V5-tagged L proteins in BSR-T7/5
cells. Cells were transfected with 0.5 mg each pTM1-based construct as indicated [panels (i) to (v)] or not transfected [panel
(vi)]. Cells were fixed with 4% paraformaldehyde, co-stained with anti-V5 mAb and anti-GM130 antibodies and examined using
the DeltaVision restoration microscope (Applied Precision). Only the merged images are shown. The insets in panels (i), (ii) and
(iv) are enlarged from the selected regions. V5-tagged L proteins stained red, the Golgi stained green and cell nuclei stained
with 4’6’-diamidino-2-phenylindole (DAPI) are shown in blue. (b) Activity of V5-tagged L proteins in the minireplicon assay.
BSR-T7/5 cells were transfected with pTM1-BUNS, pT7riboBUNMRen(”) and either wt pTM1-BUNL or V5-tagged L mutants.
Renilla luciferase activity in cell lysates was measured at 24 h post-transfection and is shown in arbitrary light units. Mock,
negative control without L cDNA; L1, pTM1-L1V5; L2, pTM1-L2V5; L3, pTM1-L3V5; L4, pTM1-L4V5; L5, pTM1-L5V5; and wt,
pTM1-BUNL.
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viruses released into the medium were comparable to that of
wt BUNV up to 24 h post-infection, though declined slightly
thereafter (Fig. 4b). Metabolic labelling of infected BHK-21
cells with [35S]methionine showed that the degree of shut-off
of host cell protein synthesis by the two recombinant viruses
was slightly slower than wt BUNV at 12 h post-infection,
but was complete by 24 h (Fig. 4c, left panel).
On Vero E6 cells, however, the recombinant viruses formed
smaller plaques than those of wt BUNV, with rL5V5
plaques being considerably smaller (Fig. 4a). The recombi-
nants grew much slower and to lower titres than wt BUNV
(Fig. 4b, central panel), in particular rL5V5 displayed the
poorest growth with virus titres nearly 1000-fold less, while
rL4V5 gave titres about 100-fold less, across the whole
infection period. In addition, shut-off of host protein
synthesis by rL4V5 and rL5V5 was obviously delayed
compared with wt BUNV (Fig. 4c).
We also investigated the growth of two recombinant
viruses on Aedes albopictus C6/36 (mosquito) cells. As
BUNV does not cause CPE or form plaques, and does not
cause marked host cell protein shut-off in insect cells
(Elliott & Wilkie, 1986), only virus growth kinetics were
examined. Notably, although rL4V5 grew nearly as
efficiently as wt BUNV, with virus titre reaching over 106
p.f.u. ml21, the growth of rL5V5 was severely retarded,
with titres of released virus only about 103 p.f.u. ml21
throughout the infection period (Fig. 4b). The results
suggest that mutations in the viral polymerase gene affect
the ability of BUNV to replicate in different cells.
Membrane association of the BUNV L protein
The distribution of the L protein in rBUNL4V5-infected
cells resembled that seen in plasmid-transfected cells (Fig.
2a), with the L protein located cytoplasmically, often
concentrated in the perinuclear region, and exhibiting a
punctate to reticular staining pattern [Fig. 5a, panel (i)].
Although bunyaviruses mature in the Golgi apparatus, no
obvious co-localization was observed between the L protein
and the Golgi marker GM130 in recombinant virus-infected
cells [Fig. 5a, panels (ii) and (iii)]. Similar observations were
made with rBUNL5V5-infected cells (data not shown).
The staining pattern exhibited by the V5-tagged L protein
suggested that the protein was likely to be associated with
intracellular membrane structures. To confirm the mem-
brane binding property of the BUNV polymerase, homo-
genized samples of virus-infected cells were fractionated by
ultracentrifugation into three fractions, total (T), soluble (S)
and microsomal (Mi), and were subjected to Western blot
analysis. This revealed that both BUNV L and N proteins
were present in both soluble and microsomal fractions (Fig.
5b). As control for the fractionation procedure, the
endoplasmic reticulum integral membrane protein calnexin
(membrane marker) and tubulin (soluble marker) were
shown to be present only in either microsomal or soluble
fractions, respectively. The presence of both N and L
proteins in the membrane fraction suggests the involvement
of membrane structures in BUNV replication.
Interaction between BUNV L and N proteins
We previously observed that the BUNV L protein was co-
immunoprecipitated with the N protein in lysates of
BUNV-infected cells (Shi et al., 2006), and this was
confirmed as shown in Fig. 6: the L protein in both
rBUNL4V5- and wt BUNV-infected cells was precipitated
by anti-N antiserum (Fig. 6a, lanes 3 and 4). The
interaction between the L and N proteins was also
demonstrated by co-precipitation with anti-V5 antibody
in which a substantial amount of the N protein was co-
precipitated from rBUNL4V5-infected cells; however, as
expected, no proteins were precipitated from wt BUNV-
infected cells (Fig. 6a, lanes 8 and 9). As controls, only the
N protein or the V5-tagged L protein was immunopreci-
pitated from cells transfected with the corresponding
individual cDNA constructs (Fig. 6a, lanes 1 and 7).
The interaction of the L and N proteins was further
investigated in BSR-T7/5 cells co-transfected with L and N
protein-expressing cDNAs (Fig. 6b). However, in this case
the protein recognized by its cognate antibody was
precipitated more efficiently than the other co-expressed
protein (e.g. compare lanes 1 and 5 with lane 9). Since this
difference may indicate that the interaction of the L and N
proteins (as in the case of transiently expressed proteins)
was relatively weak compared with N and L interaction in
RNP complexes (as would occur in virus-infected cells), we
next assessed whether co-expression of a viral transcript in
the transfected cells would increase the amount of co-
precipitating protein. Therefore, cells were transfected with
pT7riboBUNS as a source of both N protein and full-
length S segment antigenome RNA (as used in the rescue
protocol; Lowen et al., 2004) or additionally transfected with
either pT7riboBUNM(+), which expresses full-length anti-
Fig. 3. Characterization of recombinant viruses expressing epi-
tope-tagged L protein. Western blot analysis of BHK-21 and Vero
E6 cells infected with recombinant viruses rBUNL4V5 (rL4),
rBUNL5V5 (rL5) or wt BUNV (wt) at an m.o.i. of 1 p.f.u. per cell.
Extracts from equivalent numbers of cells at 36 h post-infection
were loaded into each well of a 4–12% NuPage gel (Invitrogen)
and the blot was probed with anti-V5 and anti-N antibodies.
Epitoped-tagged Bunyamwera virus
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genome M segment RNA, or the minigenome plasmid
pT7riboBUNMREN(2), which expresses a negative-sense M
segment-like RNA containing the Renilla luciferase gene,
thus reconstituting a minireplicon assay (Weber et al., 2002).
The amounts of protein in each band were estimated by
scanning the gel in a phosphorimager (FLA-5000; Fujifilm
Corporation) and use of density analysis software (Image
Gauge, version 4.21; Fujifilm Corporation and Koshin
Graphic Systems, Inc.), and by normalizing the amount of
protein expressed in the different samples, the relative degree
of co-precipitation could be assessed (see Supplementary
Table S1 available in JGV Online). In cells transfected with
pT7riboBUNS, which expresses about fourfold less N protein
than pTM1-BUNS (compare lanes 1 and 2), about eightfold
more L protein was co-precipitated with anti-N antibody,
and about fivefold more N protein was co-precipitated by the
anti-V5 antibody (compare lanes 5 and 6). The co-
transfection of pT7riboBUNM(+) (lanes 3 and 7) or
Fig. 4. Plaque phenotype, growth kinetics and protein synthesis profile of wt and recombinant viruses. (a) Comparison of
plaque size on BHK-21 and Vero E6 cells. Cell monolayers were fixed with 4% formaldehyde and stained with Giemsa solution.
(b) Viral growth curves on BHK-21, Vero E6 and Aedes albopictus C6/36 cells. Cells were infected with either wt or
recombinant viruses at an m.o.i. of 0.01 p.f.u. per cell. Virus was harvested at 8 h intervals and titrated by plaque assay. (c) Time-
course of protein synthesis on BHK-21 and Vero E6 cells. Cells infected at an m.o.i. of 1.0 p.f.u. per cell were labelled with
80 mCi (2.96 MBq) [35S]methionine for 20 min at the time points indicated and cell lysates analysed by 15% SDS-PAGE. The
positions of the viral proteins are indicated at the right.
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pT7riboBUNMREN(2) (lanes 4 and 8) also increased the
co-precipitation of the L and N proteins. This suggests that
the assembly of RNPs on viral RNA templates magnifies the
observed interaction between L and N compared with the
situation where no RNPs are present in the cell.
The association between the L and N proteins was also
visualized in rL4V5-infected BSR-T7/5 cells viewed using
the DeltaVision microscope followed by processing of the
images with deconvolution software (Fig. 5c). Both
proteins were observed throughout the cytoplasm with L
being more perinuclearly localized, whereas N showed a
more general cytoplasmic distribution. The majority of the
L protein appeared to co-localize with N, forming a
network structure [see the enlarged region in Fig. 6c panel
(iii) with co-localizaion shown in yellow]. These images are
again consistent with L and N interaction occurring on
intracellular membranes.
DISCUSSION
The bunyavirus L protein, like the polymerases of other
negative-strand viruses, plays a key role in the virus life
cycle, including genome replication and mRNA transcrip-
tion. Study of some aspects of the BUNV L protein has
been impeded by the lack of an antibody that can recognize
the native or functional protein in cells by immunofluor-
escent detection methods, as the antibodies previously
raised against BUNV L protein were only able to detect the
protein by immunoprecipitation and Western blotting (Jin
& Elliott, 1992), or by immunogold labelling of thin
sections of fixed infected cells and electron microscopy
(Fontana et al., 2008). Therefore, we attempted to
introduce an epitope tag into the L protein and determined
whether the recombinant polymerase proteins would be (i)
functional and (ii) recognized by the cognate antibody. To
this end, we inserted the V5 epitope at different positions
in the coding region of the BUNV L protein based on
sequence comparison and bioinformatic predictions
(Fig. 1). Insertion at two positions towards the C terminus
of L resulted in recombinant proteins that retained
functionality in a minireplicon assay, and in turn could
be incorporated into infectious viruses.
Little is known about the domain structure of bunyavirus
polymerases. Muller et al. (1994) compared the L protein
Fig. 5. Membrane association of viral proteins. (a) Punctate staining pattern of the BUNV L protein in rBUNL4V5-infected
BSR-T7/5 cells. Cells were infected with rBUNL4V5 at an m.o.i. of 5, fixed and then co-stained with anti-V5 (red) and anti-
GM130 (Golgi marker, green) antibodies. An enlarged area from panel (iii) is also shown. (b) Western blotting analysis of
subcellular fractions of rBUNL4V5-infected BHK-21 cells. Cells were infected with rBUNL4V5 at an m.o.i. of 5 p.f.u. per cell.
Cells were homogenized and fractionated as described in Methods. The presence of the L and N proteins was determined by
Western blotting with anti-V5 and anti-BUNV N antibodies as appropriate. Tubulin and calnexin were used as soluble and
membrane protein markers, respectively, and detected with appropriate antibodies. T, Total cell lysate; S, soluble fraction and
Mi, microsomal fractions.
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sequences of bunyaviruses and arenaviruses (the other
family of cytoplasmic-replicating, segmented genome,
negative-sense RNA viruses) and identified three conserved
regions, two near the N terminus (regions 1 and 2) and one
in the centre (region 3). The C termini of the proteins were
found to be more variable. Insertion of the V5 epitope at
position 148 (construct L1V5) in region 1 of the BUNV L
protein appeared not to disrupt the structure of the protein,
as the intracellular distribution of L1V5 was indistinguish-
able from that of the two functional constructs L4V5 and
L5V5. However, the abolition of polymerase activity by V5
insertion at this position indicated the importance of this
region in virus replication, though a specific function has yet
to be ascribed to region 1.
Construct L2V5 has the epitope inserted at position 428,
situated between regions 1 and 2, and there is no significant
conservation of amino acids among the L proteins of
viruses in the five bunyavirus genera in this area. However,
perturbation of this ‘linking’ region resulted in misfolding
of the BUNV L protein, suggesting that the region may be
required for maintaining polymerase structure. Insertion of
V5 at position 863 (construct L3V5), which is in a variable
domain upstream of region 3 (which contains the
polymerase module present in all the RdRps), also
abolished polymerase activity. However, V5 insertion at
positions 1935 and 2046 (constructs L4V5 and L5V5) had
no lethal impact on polymerase activity, and two
recombinant viruses expressing tagged L protein were
recovered, suggesting that the variable C-terminal region of
BUNV polymerase is more tolerant of mutation than other
regions.
Comparison of the recombinant viruses expressing tagged
L protein and wt BUNV revealed that the viruses behaved
differentially in different cell lines with regards to plaque
size, growth kinetics, and protein synthesis profile. Cell-
type-dependent effects on virus growth suggest that the V5
Fig. 6. Interaction of the BUNV L and N proteins. (a and b) Co-immunoprecipitation assays. BSR-T7/5 cells were either
transfected with cDNA constructs or infected with wt BUNV or recombinant viruses as indicated. Cells were labelled with
[35S]methionine and were immunoprecipitated with either anti-N or anti-V5 antibodies. The positions of the BUNV L and N
proteins are indicated at the right. (c) DeltaVision microscopic images of BSR-T7/5 cells infected with rBUNL4V5. Cells were
stained with anti-V5 [red, panel (i)] and anti-N [green, panel (ii)] antibodies, and merged images are shown in panel (iii). Co-
localization is shown in yellow. Nuclei were stained blue with DAPI. An enlarged area from panel (iii) is also shown.
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insertion in the L protein likely affects the interaction of
the viral polymerase with host factors required for
replication. Cell-type dependence for mRNA synthesis
was reported for LACV (Raju et al., 1989), and it was
described recently that a host factor that bound to the
polymerase of tomato spotted wilt virus, a plant-and-
insect-infecting bunyavirus, was able to render human cell
lines permissive for virus replication (Medeiros et al.,
2005). Our data suggest that the C-terminal region of the
BUNV L protein, especially the region around residue 2046
(the site of insertion of the epitope in construct L5V5) is
perhaps involved in the interaction with a cellular co-
factor(s). Experiments are ongoing to identify cellular
proteins that interact with the epitope-tagged L proteins.
Bunyaviruses replicate in the cytoplasm of infected cells
(Kuismanen et al., 1982; Murphy et al., 1973; Schmaljohn
& Hooper, 2001). In this study, the L protein was clearly
shown distributed in the cytoplasm with a punctate to
reticular staining pattern in cells that were either
transfected with functional V5-tagged L segment cDNAs
or infected by recombinant viruses; in some cells there was
a concentration of staining in the perinuclear region. A
cytoplasmic punctate staining pattern was also reported for
the L protein of TOSV, though the TOSV L antibodies also
recognized smaller forms of L, perhaps derived from
defective RNAs. Hence the localization of full-length,
functional L protein was unclear (Di Bonito et al., 1999).
For TULV, the L protein antibodies also failed to recognize
the protein in immunofluorescent assays (Kukkonen et al.,
2004), but a TULV L–GFP fusion protein was observed in
the perinuclear region of plasmid-transfected cells, though
the functional significance of this could not be ascertained
(Kukkonen et al., 2004, 2005). Thus, our data with epitope-
tagged recombinant BUNV represent the bona fide picture
of viral polymerase distribution during virus infection.
The punctate expression pattern of TULV L–GFP was
interpreted as indicating an association of the protein with
intracellular membranes, and indeed the TULV L protein
was found in the microsomal membrane fraction of
infected cells (Kukkonen et al., 2004). The V5-tagged
BUNV L, as well as the N protein, was detected in both
cytosolic and microsomal fractions (Fig. 5). We suggest
that the cytosolic fraction contains newly made soluble
proteins, while the membrane-associated proteins repres-
ent replication complexes. This is consistent with the
observations of Fontana et al. (2008) that also suggest the
BUNV replication complex is associated with intracellular
membrane compartments. Further characterization of
these membranes is ongoing, and the epitope-tagged L
protein expressing viruses will be valuable reagents in these
studies. Furthermore, the success of tagging the BUNV L
protein with the V5 epitope suggests it may be possible to
insert longer sequences into the polymerase, such as GFP
or other fluorescent tags, as has been achieved for the viral
polymerases of measles, rinderpest and canine distemper
viruses (Brown et al., 2005; Duprex et al., 2002; Silin et al.,
2007).
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